C. Jillian Tsai
Papers
1
Total Citations
57
H-Index
1
About
Dr. C. Jillian Tsai is a leading radiation oncologist whose research focuses on treatment deintensification for HPV-associated oropharyngeal cancer (OPC), a malignancy whose incidence has surged dramatically in recent decades. Her landmark 2022 paper, “Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer,” has garnered 57 citations and serves as a critical roadmap for the field. In this work, Dr. Tsai synthesizes the pressing need to reduce the severe, long-term toxicities of standard chemoradiation—such as swallowing dysfunction and fibrosis—while maintaining excellent cure rates in HPV-positive patients, who typically have a favorable prognosis. Her contributions have helped shape clinical trials and guidelines that explore de-escalation strategies, including reduced radiation doses and the omission of chemotherapy. By bridging consensus and controversy, Dr. Tsai has empowered clinicians to personalize treatment, sparing patients unnecessary harm without compromising outcomes. Her research is pivotal in an era where rising OPC cases demand smarter, less morbid therapies, making her a key voice in oncologic innovation and patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1